Abstract
Background: Histone deacetylase inhibitors (HDACi) have therapeutic effects on various models of renal diseases including autosomal dominant polycystic kidney disease (ADPKD), but the molecular mechanism is unclear. Objectives: Here, we studied the role of trichostatin A (TSA), a specific HDACi, in regulating cyst growth to test the possibility that HDACi might help manage ADPKD by enhancing autophagy. Results: Autophagy protein expression was higher in cultured Pkd1 knockout (Pkd1<sup>–/–</sup>) cells, an in vitro model of cystogenesis, compared with control cells. TSA prevented cyst formation in Pkd1<sup>–/–</sup> cells. We further tested whether TSA could not reduce the size of an already established cyst after inhibition of autophagy by chloroquine in Pkd1<sup>–/–</sup> cells. In vivo, treatment with TSA significantly slowed cyst growth in Pkd1<sup>–/–</sup> mice. Moreover, TSA treatment stimulated AMPK and inactivated mTOR during cyst growth in Pkd1<sup>–/–</sup> cells and kidneys in mice. Conclusions: Our results suggest that HDACi may prevent cyst formation by activation of the AMPK pathway and autophagy. They also imply that HDACi could have therapeutic potential for ADPKD treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
